OVID vs RTX · rev $733.0K vs P/E 36, rev $46.78B
Ovid Therapeutics Inc (OVID) versus RTX Corporation (RTX) — a side-by-side from cached financials, not a winner call.
Ovid Therapeutics Inc (OVID) is a biotechnology company listed on US.
RTX Corporation (RTX) is a aerospace & defense company listed on NYSE. It is led by Chris Calio.
Latest reported OVID revenue for 2026-06-30 was $733.0K. Net income was -$32.0M. OVID currently screens at market cap $23.5M.
Latest reported RTX revenue for 2026-06-30 was $46.78B. Net income was $4.20B. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
OVID currently screens at market cap $23.5M. RTX currently screens at market cap $259.34B and trailing P/E 36.2.
Not investment advice. Open the OVID and RTX stock pages for the full models.
Not investment advice.